Cibc Asset Management Inc Keros Therapeutics, Inc. Transaction History

Cibc Asset Management Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$41.44 - $59.32 $1.78 Million - $2.54 Million	-42,842 Reduced 47.53%	47,304 $2.02 Million
Q4 2022 Feb 13, 2023	SELL	$39.45 - $51.77 $2.22 Million - $2.91 Million	-56,222 Reduced 38.41%	90,146 $4.33 Million
Q3 2022 Nov 03, 2022	BUY	$27.8 - $40.12 $4.07 Million - $5.87 Million	146,368 New	146,368 $5.51 Million

174

30.3M

76.8K

Ticker KROS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,757,000
Market Cap $403M
Description
Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...

Get notified when there are updates to the investment portfolio of Cibc Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Cibc Asset Management Inc with notifications on news.